Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

Angiotensin receptor blockers (ARBs) used in the treatment of hypertension and potentially in SARS-CoV-2 infection exhibit inverse agonist effects at angiotensin AR1 receptors, suggesting the receptor may have evolved to accommodate naturally occurring angiotensin ‘antipeptides’. Screening of the hu...

Full description

Bibliographic Details
Main Authors: Graham J. Moore, Harry Ridgway, Konstantinos Kelaidonis, Christos T. Chasapis, Irene Ligielli, Thomas Mavromoustakos, Joanna Bojarska, John M. Matsoukas
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Molecules
Subjects:
COVID-19
angiotensin II
angiotensin II receptors
biased agonism
molecular dynamics (MD)
angiotensin II receptor blockers (ARBS)
Online Access:https://www.mdpi.com/1420-3049/27/15/4854

Internet

https://www.mdpi.com/1420-3049/27/15/4854

Similar Items